| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/24/2011 | US20110041262 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors |
| 02/24/2011 | CA2771790A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | CA2771609A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | CA2771532A1 Heterocyclic compounds and uses thereof |
| 02/24/2011 | CA2771484A1 Substituted benzoazepines as toll-like receptor modulators |
| 02/24/2011 | CA2771234A1 Substituted hydrazide compounds and use thereof |
| 02/24/2011 | CA2770766A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | CA2770178A1 A process for the synthesis of naratriptan |
| 02/24/2011 | CA2769998A1 Imatinib immunoassay |
| 02/23/2011 | EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2011 | EP2287155A1 Acylthiourea compound or salt thereof, and use of the compound or the salt |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2285803A1 5-lipoxygenase-activating protein inhibitor |
| 02/23/2011 | EP2285800A1 Quinoline or isoquinoline substituted p2x7 antagonists |
| 02/23/2011 | EP2285799A2 Method for preparing argatroban monohydrate |
| 02/23/2011 | EP2285798A1 Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia |
| 02/23/2011 | EP2285787A2 3-substituted propanamine compounds |
| 02/23/2011 | EP2285783A1 Indazole compounds as ccr1 receptor antagonists |
| 02/23/2011 | EP2285781A1 5-methyl-1-(naphthalen-2-yl)-1h-pyrazoles useful as sigma receptor inhibitors |
| 02/23/2011 | EP2285778A1 Nicotinamide derivatives |
| 02/23/2011 | EP2285376A1 6-aminonicotinamide derivatives as potent and selective histone deacetylase inhibitors |
| 02/23/2011 | EP2155721B1 Organic compounds |
| 02/23/2011 | EP2084144B1 Synthesis of piperazines, piperidines and related compounds |
| 02/23/2011 | EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 02/23/2011 | EP1958946B1 Pyridazine compound and use thereof |
| 02/23/2011 | EP1954696B1 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 02/23/2011 | EP1919905B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases |
| 02/23/2011 | EP1885712B1 New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides. |
| 02/23/2011 | EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 02/23/2011 | EP1805164B1 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 02/23/2011 | EP1737843B1 Inhibitors of akt activity |
| 02/23/2011 | EP1737451B1 Monocyclic heterocycles as kinase inhibitors |
| 02/23/2011 | EP1697347B1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 02/23/2011 | EP1682520B1 Amide derivatives |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | CN1942466B Caspase inhibitors and uses thereof |
| 02/23/2011 | CN1882549B 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/23/2011 | CN1419537B Insecticidal anthranilamides |
| 02/23/2011 | CN101981027A Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 02/23/2011 | CN101981026A Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981024A Acenaphthopyridine derivative, material of light-emitting element, light-emitting element, light-emitting device, and electronic appliance |
| 02/23/2011 | CN101981015A 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101981013A Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |
| 02/23/2011 | CN101981010A 酰胺化合物 Amide compounds |
| 02/23/2011 | CN101981009A 2-trifluoromethylnicotinamide derivatives as HDL-cholesterol raising agents |
| 02/23/2011 | CN101981008A 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors |
| 02/23/2011 | CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/23/2011 | CN101039907B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/22/2011 | US7893278 Antiproliferative agents; antitumor agents; anticancer agents |
| 02/22/2011 | US7893092 e.g. 2-(3-chloro-pyridin-2-yl)-5-trifluoromethyl-2H-pyrazole-3-carboxylic acid [4-chloro-2-(2-methanesulfinyl-propylcarbamoyl)-6-methyl-phenyl]-amide; controlling insects or representatives of the order Acarina |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893079 Substituted monocyclic CGRP receptor antagonists |
| 02/22/2011 | US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide |
| 02/22/2011 | US7893073 Heterocyclic derivatives |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893069 Substituted imidazo[2,1-b]thiazole compounds and uses thereof |
| 02/22/2011 | US7893065 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 02/22/2011 | US7893061 Alkyne-substituted pyridone compounds and methods of use |
| 02/22/2011 | US7893052 CGRP receptor antagonists |
| 02/22/2011 | US7893049 Thiazolyl-dihydro-indazole |
| 02/22/2011 | US7892748 Reagent for detecting an analyte |
| 02/22/2011 | US7892297 Cyanin-type compounds having an alkynyl linker arm |
| 02/22/2011 | CA2553879C Viral polymerase inhibitors |
| 02/22/2011 | CA2533509C Piperidine compounds and pharmaceutical compositions containing them |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011019634A2 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | WO2011019375A1 Treatment of bdnf-related disorders using laquinimod |
| 02/17/2011 | WO2011019090A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
| 02/17/2011 | WO2011019089A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
| 02/17/2011 | WO2011019060A1 Hedgehog signal inhibitor |
| 02/17/2011 | WO2011018518A1 Regioselective preparation of 2 -amino-5-trifluoromethylpyrimidine derivatives |
| 02/17/2011 | WO2011018417A1 Inhibitors of jnk |
| 02/17/2011 | WO2011018101A1 Lenalidomide salts |
| 02/17/2011 | WO2010122980A8 NOVEL THYROID HORMONE β RECEPTOR AGONIST |
| 02/17/2011 | WO2010117979A3 Serotonin and norepinephrine reuptake inhibitor |
| 02/17/2011 | US20110040078 Process for the production of telithromycin |
| 02/17/2011 | US20110039896 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 02/17/2011 | US20110039895 Prolyl hydroxylase inhibitors |
| 02/17/2011 | US20110039893 Gsk-3beta inhibitor |
| 02/17/2011 | US20110039892 Iminopyridine derivative and use thereof |
| 02/17/2011 | US20110039891 Methods for treating a disease in which Rho kinase is involved |
| 02/17/2011 | US20110039888 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones |
| 02/17/2011 | US20110039887 Carbostyril derivatives including cilostazol for treating fatty liver |
| 02/17/2011 | US20110039880 Aryl substituted sulfonamide compounds and their use as anticancer agents |
| 02/17/2011 | US20110039867 Pyrimidine derivatives which are antagonist of the vitronectin receptor |
| 02/17/2011 | US20110039866 Selective sphingosine-1-phosphate receptor antagonists |
| 02/17/2011 | US20110039864 Therapeutic compounds |
| 02/17/2011 | US20110039861 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/17/2011 | US20110039860 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment |
| 02/17/2011 | US20110039857 Piperidine and pyroolidine compounds |
| 02/17/2011 | US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators |
| 02/17/2011 | US20110039851 Ccr10 antagonists |
| 02/17/2011 | US20110039847 Amide derivatives as sirtuin modulators |